{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["16S rDNA", "DSS", "colitis", "gut microbiota", "indigo naturalis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31726738", "DateCompleted": {"Year": "2020", "Month": "04", "Day": "03"}, "DateRevised": {"Year": "2020", "Month": "04", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "11", "Day": "12"}], "Language": ["eng"], "ELocationID": ["4086", "10.3390/molecules24224086"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "24", "Issue": "22", "PubDate": {"Year": "2019", "Month": "Nov", "Day": "12"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Indigo Naturalis Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulating the Intestinal Microbiota Community.", "Abstract": {"AbstractText": ["Indigo naturalis (IN) is a traditional Chinese medicine, named Qing-Dai, which is extracted from indigo plants and has been used to treat patients with inflammatory bowel disease (IBD) in China and Japan. Though there are notable effects of IN on colitis, the mechanisms remain elusive. Regarding the significance of alterations of intestinal flora related to IBD and the poor water solubility of the blue IN powder, we predicted that the protective action of IN on colitis may occur through modifying gut microbiota. To investigate the relationships of IN, colitis, and gut microbiomes, a dextran sulfate sodium (DSS)-induced mice colitis model was tested to explore the protective effects of IN on macroscopic colitis symptoms, the histopathological structure, inflammation cytokines, and gut microbiota, and their potential functions. Sulfasalazine (SASP) was used as the positive control. Firstly, because it was a mixture, the main chemical compositions of indigo and indirubin in IN were detected by ultra-performance liquid chromatography (UPLC). The clinical activity score (CAS), hematoxylin and eosin (H&E) staining results, and enzyme-linked immunosorbent assay (ELISA) results in this study showed that IN greatly improved the health conditions of the tested colitis mice, ameliorated the histopathological structure of the colon tissue, down-regulated pro-inflammatory cytokines, and up-regulated anti-inflammatory cytokines. The results of 16S rDNA sequences analysis with the Illumina MiSeq platform showed that IN could modulate the balance of gut microbiota, especially by down-regulating the relative quantity of <i>Turicibacter</i> and up-regulating the relative quantity of <i>Peptococcus</i>. The therapeutic effect of IN may be closely related to the anaerobic gram-positive bacteria of <i>Turicibacter</i> and <i>Peptococcus.</i> The inferred metagenomes from 16S data using PICRUSt demonstrated that decreased metabolic genes, such as through biosynthesis of siderophore group nonribosomal peptides, non-homologous end-joining, and glycosphingolipid biosynthesis of lacto and neolacto series, may maintain microbiota homeostasis during inflammation from IN treatment in DSS-induced colitis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xian Yang 712083, China."}], "LastName": "Liang", "ForeName": "Yan-Ni", "Initials": "YN"}, {"Identifier": ["0000-0003-0260-3334"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xian Yang 712083, China."}], "LastName": "Yu", "ForeName": "Jin-Gao", "Initials": "JG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xian Yang 712083, China."}], "LastName": "Zhang", "ForeName": "Dong-Bo", "Initials": "DB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xian Yang 712083, China."}], "LastName": "Zhang", "ForeName": "Zhen", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xian Yang 712083, China."}], "LastName": "Ren", "ForeName": "Lang-Lang", "Initials": "LL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xian Yang 712083, China."}], "LastName": "Li", "ForeName": "Lu-Han", "Initials": "LH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xian Yang 712083, China."}], "LastName": "Wang", "ForeName": "Zheng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xian Yang 712083, China."}], "LastName": "Tang", "ForeName": "Zhi-Shu", "Initials": "ZS"}], "GrantList": [{"GrantID": "81803951", "Agency": "National Natural Science Foundation of China", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammation Mediators"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Ribosomal, 16S"}, {"RegistryNumber": "9042-14-2", "NameOfSubstance": "Dextran Sulfate"}, {"RegistryNumber": "D3741U8K7L", "NameOfSubstance": "Indigo Carmine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Biopsy"}, {"QualifierName": ["drug therapy", "etiology", "metabolism", "pathology"], "DescriptorName": "Colitis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Dextran Sulfate"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gastrointestinal Microbiome"}, {"QualifierName": [], "DescriptorName": "Immunohistochemistry"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Indigo Carmine"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammation Mediators"}, {"QualifierName": ["drug effects", "metabolism", "microbiology", "pathology"], "DescriptorName": "Intestinal Mucosa"}, {"QualifierName": [], "DescriptorName": "Metagenomics"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "RNA, Ribosomal, 16S"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Pizzi L.T., Weston C.M., Goldfarb N.I., Moretti D., Cobb N., Howell J.B., Infantolino A., Dimarino A.J., Cohen S. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm. Bowel. Dis. 2006;12:47\u201352. doi: 10.1097/01.MIB.0000191670.04605.e7.", "ArticleIdList": ["10.1097/01.MIB.0000191670.04605.e7", "16374258"]}, {"Citation": "Walker A.W., Sanderson J.D., Churcher C., Parkes G.C., Hudspith B.N., Rayment N., Brostoff J., Parkhill J., Dougan G., Petrovska L. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 2011;11:7\u201319. doi: 10.1186/1471-2180-11-7.", "ArticleIdList": ["10.1186/1471-2180-11-7", "PMC3032643", "21219646"]}, {"Citation": "Ng S.C., Shi H.Y., Hamidi N., Underwood F.E., Tang W., Benchimol E.I., Panaccione R., Ghosh S., Wu J.C.Y., Chan F.K.L., et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017;390:2769\u20132778. doi: 10.1016/S0140-6736(17)32448-0.", "ArticleIdList": ["10.1016/S0140-6736(17)32448-0", "29050646"]}, {"Citation": "Triantafillidis J.K., Merikas E., Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des. Dev. Ther. 2011;5:185\u2013210. doi: 10.2147/DDDT.S11290.", "ArticleIdList": ["10.2147/DDDT.S11290", "PMC3084301", "21552489"]}, {"Citation": "Peppercorn M.A. Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development. Ann. Intern. Med. 1984;101:377\u2013386. doi: 10.7326/0003-4819-101-3-377.", "ArticleIdList": ["10.7326/0003-4819-101-3-377", "6147110"]}, {"Citation": "Legaki E., Gazouli M. Influence of environmental factors in the development of inflammatory bowel diseases. World J. Gastrointest Pharm. 2016;7:112\u2013125. doi: 10.4292/wjgpt.v7.i1.112.", "ArticleIdList": ["10.4292/wjgpt.v7.i1.112", "PMC4734944", "26855817"]}, {"Citation": "Khor B., Gardet A., Xavier R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307\u2013317. doi: 10.1038/nature10209.", "ArticleIdList": ["10.1038/nature10209", "PMC3204665", "21677747"]}, {"Citation": "de Souza H.S., Fiocchi C. Immunopathogenesis of IBD: Current state of the art. Nat. Rev. Gastroenterol. Hepatol. 2016;13:13\u201327. doi: 10.1038/nrgastro.2015.186.", "ArticleIdList": ["10.1038/nrgastro.2015.186", "26627550"]}, {"Citation": "Zhang S.L., Wang S.N., Miao C.Y. Influence of microbiota on intestinal immune system in ulcerative colitis and its intervention. Front. Immunol. 2017;8:1674. doi: 10.3389/fimmu.2017.01674.", "ArticleIdList": ["10.3389/fimmu.2017.01674", "PMC5712343", "29234327"]}, {"Citation": "Wlodarska M., Kostic A.D., Xavier R.J. An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe. 2015;17:577\u2013591. doi: 10.1016/j.chom.2015.04.008.", "ArticleIdList": ["10.1016/j.chom.2015.04.008", "PMC4498258", "25974300"]}, {"Citation": "Lee T., Clavel T., Smirnov K., Schmidt A., Lagkouvardos I., Walker A., Lucio M., Michalke B., Schmitt-Kopplin P., Fedorak R., et al. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017;66:863\u2013871. doi: 10.1136/gutjnl-2015-309940.", "ArticleIdList": ["10.1136/gutjnl-2015-309940", "PMC5531225", "26848182"]}, {"Citation": "Lopez-Siles M., Duncan S.H., Garcia-Gil L.J., Martinez-Medina M. Faecalibacterium prausnitzii: From microbiology to diagnostics and prognostics. ISME J. 2017;11:841\u2013852. doi: 10.1038/ismej.2016.176.", "ArticleIdList": ["10.1038/ismej.2016.176", "PMC5364359", "28045459"]}, {"Citation": "Kabeerdoss J., Sankaran V., Pugazhendhi S., Ramakrishna B.S. Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: A case-control study in India. BMC Gastroenterol. 2013;13:20. doi: 10.1186/1471-230X-13-20.", "ArticleIdList": ["10.1186/1471-230X-13-20", "PMC3565871", "23351032"]}, {"Citation": "Prosberg M., Bendtsen F., Vind I., Petersen A.M., Gluud L.L. The association between the gut microbiota and the inflammatory bowel disease activity: A systematic review and meta-analysis. Scand. J. Gastroenterol. 2016;51:1407\u20131415. doi: 10.1080/00365521.2016.1216587.", "ArticleIdList": ["10.1080/00365521.2016.1216587", "27687331"]}, {"Citation": "Jeon S.G., Kayama H., Ueda Y., Takahashi T., Asahara T., Tsuji H., Tsuji N.M., Kiyono H., Ma J.S., Kusu T., et al. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PloS Pathog. 2012;8:e1002714. doi: 10.1371/journal.ppat.1002714.", "ArticleIdList": ["10.1371/journal.ppat.1002714", "PMC3364948", "22693446"]}, {"Citation": "Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453:620\u2013625. doi: 10.1038/nature07008.", "ArticleIdList": ["10.1038/nature07008", "18509436"]}, {"Citation": "Keenan J.I., Beaugie C.R., Jasmann B., Potter H.C., Collett J.A., Frizelle F.A. Helicobacter species in the human colon. Colorectal. Dis. 2010;12:48\u201353. doi: 10.1111/j.1463-1318.2008.01672.x.", "ArticleIdList": ["10.1111/j.1463-1318.2008.01672.x", "20050183"]}, {"Citation": "Machiels K., Joossens M., Sabino J., De Preter V., Arijs I., Eeckhaut V., Ballet V., Claes K., Van Immerseel F., Verbeke K., et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63:1275\u20131283. doi: 10.1136/gutjnl-2013-304833.", "ArticleIdList": ["10.1136/gutjnl-2013-304833", "24021287"]}, {"Citation": "Vermeiren J., Van den Abbeele P., Laukens D., Vigsnaes L.K., De Vos M., Boon N., Van de Wiele T. Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment. Fems Microbiol. Ecol. 2012;79:685\u2013696. doi: 10.1111/j.1574-6941.2011.01252.x.", "ArticleIdList": ["10.1111/j.1574-6941.2011.01252.x", "22092917"]}, {"Citation": "Knoll R.L., Forslund K., Kultima J.R., Meyer C.U., Kullmer U., Sunagawa S., Bork P., Gehring S. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: A metagenomic analysis. Am. J. Physiol. Gastrointest Liver Physiol. 2017;312:G327\u2013G339. doi: 10.1152/ajpgi.00293.2016.", "ArticleIdList": ["10.1152/ajpgi.00293.2016", "28039159"]}, {"Citation": "Martinez-Medina M., Garcia-Gil L.J. Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity. World J. Gastrointest Pathophysiol. 2014;5:213\u2013227. doi: 10.4291/wjgp.v5.i3.213.", "ArticleIdList": ["10.4291/wjgp.v5.i3.213", "PMC4133521", "25133024"]}, {"Citation": "Bashir A., Miskeen A.Y., Hazari Y.M., Asrafuzzaman S., Fazili K.M. Fusobacterium nucleatum, inflammation, and immunity: The fire within human gut. Tumour Biol. 2016;37:2805\u20132810. doi: 10.1007/s13277-015-4724-0.", "ArticleIdList": ["10.1007/s13277-015-4724-0", "26718210"]}, {"Citation": "Yao P., Cui M., Wang H., Gao H., Wang L., Yang T., Cheng Y. Quantitative analysis of intestinal flora of Uygur and Han ethnic Chinese patients with ulcerative colitis. Gastroenterol. Res. Pr. 2016;2016:9186232. doi: 10.1155/2016/9186232.", "ArticleIdList": ["10.1155/2016/9186232", "PMC4709672", "26839545"]}, {"Citation": "Zwolinska-Wcislo M., Brzozowski T., Budak A., Kwiecien S., Sliwowski Z., Drozdowicz D., Trojanowska D., Rudnicka-Sosin L., Mach T., Konturek S.J., et al. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. J. Physiol. Pharm. 2009;60:107\u2013118. doi: 10.1007/s12576-008-0010-x.", "ArticleIdList": ["10.1007/s12576-008-0010-x", "19439813"]}, {"Citation": "Khan I., Ullah N., Zha L., Bai Y., Khan A., Zhao T., Che T., Zhang C. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens. 2019;8:126. doi: 10.3390/pathogens8030126.", "ArticleIdList": ["10.3390/pathogens8030126", "PMC6789542", "31412603"]}, {"Citation": "Jing Y., Li A., Liu Z., Yang P., Wei J., Chen X., Zhao T., Bai Y., Zha L., Zhang C. Absorption of Codonopsis pilosula saponins by coexisting polysaccharides alleviates gut microbial dysbiosis with dextran sulfate sodium-induced colitis in model mice. Biomed. Res. Int. 2018;2018:18. doi: 10.1155/2018/1781036.", "ArticleIdList": ["10.1155/2018/1781036", "PMC6120299", "30211217"]}, {"Citation": "Yang Y., Chen G., Yang Q., Ye J., Cai X., Tsering P., Cheng X., Hu C., Zhang S., Cao P. Gut microbiota drives the attenuation of dextran sulphate sodium-induced colitis by Huangqin decoction. Oncotarget. 2017;8:48863\u201348874. doi: 10.18632/oncotarget.16458.", "ArticleIdList": ["10.18632/oncotarget.16458", "PMC5564731", "28415628"]}, {"Citation": "Sugimoto S., Naganuma M., Kanai T. Indole compounds may be promising medicines for ulcerative colitis. J. Gastroenterol. 2016;51:853\u2013861. doi: 10.1007/s00535-016-1220-2.", "ArticleIdList": ["10.1007/s00535-016-1220-2", "27160749"]}, {"Citation": "Naganuma M., Sugimoto S., Mitsuyama K., Kobayashi T., Yoshimura N., Ohi H., Tanaka S., Andoh A., Ohmiya N., Saigusa K., et al. Efficacy of Indigo Naturalis in a multicenter randomized controlled trial of patients with ulcerative colitis. Gastroenterology. 2018;154:935\u2013947. doi: 10.1053/j.gastro.2017.11.024.", "ArticleIdList": ["10.1053/j.gastro.2017.11.024", "29174928"]}, {"Citation": "Matsuno Y., Hirano A., Torisu T., Okamoto Y., Fuyuno Y., Fujioka S., Umeno J., Moriyama T., Nagai S., Hori Y., et al. Short-term and long-term outcomes of indigo naturalis treatment for inflammatory bowel disease. J. Gastroenterol. Hepatol. 2019 doi: 10.1111/jgh.14823.", "ArticleIdList": ["10.1111/jgh.14823", "31389626"]}, {"Citation": "Naganuma M., Sugimoto S., Fukuda T., Mitsuyama K., Kobayashi T., Yoshimura N., Ohi H., Tanaka S., Andoh A., Ohmiya N., et al. Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: A post hoc analysis from the INDIGO study. J. Gastroenterol. 2019 doi: 10.1007/s00535-019-01625-2.", "ArticleIdList": ["10.1007/s00535-019-01625-2", "31529220"]}, {"Citation": "Fukunaga K., Ohda Y., Hida N., Iimuro M., Yokoyama Y., Kamikozuru K., Nagase K., Nakamura S., Miwa H., Matsumoto T. Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis. J. Gastroenterol. Hepatol. 2012;27:1808\u20131815. doi: 10.1111/j.1440-1746.2012.07215.x.", "ArticleIdList": ["10.1111/j.1440-1746.2012.07215.x", "22775479"]}, {"Citation": "Zhang F., Li Y., Xu F., Chu Y., Zhao W. Comparison of Xilei-san, a Chinese herbal medicine, and dexamethasone in mild/moderate ulcerative proctitis: A double-blind randomized clinical trial. J. Altern. Complementary Med. 2013;19:838\u2013842. doi: 10.1089/acm.2012.0296.", "ArticleIdList": ["10.1089/acm.2012.0296", "23383973"]}, {"Citation": "Xiao H.T., Peng J., Hu D.D., Lin C.Y., Du B., Tsang S.W., Lin Z.S., Zhang X.J., Lueng F.P., Han Q.B., et al. Qing-dai powder promotes recovery of colitis by inhibiting inflammatory responses of colonic macrophages in dextran sulfate sodium-treated mice. Chin. Med. 2015;10:29. doi: 10.1186/s13020-015-0061-x.", "ArticleIdList": ["10.1186/s13020-015-0061-x", "PMC4604072", "26464580"]}, {"Citation": "Wang Y., Liu L., Guo Y., Mao T., Shi R., Li J. Effects of indigo naturalis on colonic mucosal injuries and inflammation in rats with dextran sodium sulphate-induced ulcerative colitis. Exp. Med. 2017;14:1327\u20131336. doi: 10.3892/etm.2017.4701.", "ArticleIdList": ["10.3892/etm.2017.4701", "PMC5526181", "28781623"]}, {"Citation": "Adachi J., Mori Y., Matsui S., Takigami H., Fujino J., Kitagawa H., Miller C.A., 3rd, Kato T., Saeki K., Matsuda T. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem. 2001;276:31475\u201331478. doi: 10.1074/jbc.C100238200.", "ArticleIdList": ["10.1074/jbc.C100238200", "11425848"]}, {"Citation": "Tokuyasu N., Shomori K., Amano K., Honjo S., Sakamoto T., Watanabe J., Amisaki M., Morimoto M., Uchinaka E., Yagyu T., et al. Indirubin, a constituent of the Chinese herbal medicine Qing-Dai, attenuates dextran sulfate sodium-induced murine colitis. Yonago Acta Med. 2018;61:128\u2013136. doi: 10.33160/yam.2018.06.005.", "ArticleIdList": ["10.33160/yam.2018.06.005", "PMC6015798", "29946219"]}, {"Citation": "Kawai S., Iijima H., Shinzaki S., Hiyama S., Yamaguchi T., Araki M., Iwatani S., Shiraishi E., Mukai A., Inoue T., et al. Indigo Naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation. J. Gastroenterol. 2017;52:904\u2013919. doi: 10.1007/s00535-016-1292-z.", "ArticleIdList": ["10.1007/s00535-016-1292-z", "27900483"]}, {"Citation": "Basu R., O\u2019Quinn D.B., Silberger D.J., Schoeb T.R., Fouser L., Ouyang W., Hatton R.D., Weaver C.T. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity. 2012;37:1061\u20131075. doi: 10.1016/j.immuni.2012.08.024.", "ArticleIdList": ["10.1016/j.immuni.2012.08.024", "PMC3678257", "23200827"]}, {"Citation": "Wang Z., Wu X., Wang C.L., Wang L., Sun C., Zhang D.B., Liu J.L., Liang Y.N., Tang D.X., Tang Z.S. Tryptanthrin protects mice against dextran sulfate sodium-induced colitis through inhibition of TNF-alpha/NF-kappaB and IL-6/STAT3 pathways. Molecules. 2018;23:1062. doi: 10.3390/molecules23051062.", "ArticleIdList": ["10.3390/molecules23051062", "PMC6099556", "29724065"]}, {"Citation": "Pandurangan A.K., Mohebali N., Hasanpourghadi M., Looi C.Y., Mustafa M.R., Mohd Esa N. Boldine suppresses dextran sulfate sodium-induced mouse experimental colitis: NF-kappaB and IL-6/STAT3 as potential targets. BioFactors. 2016;42:247\u2013258. doi: 10.1002/biof.1267.", "ArticleIdList": ["10.1002/biof.1267", "26891685"]}, {"Citation": "Ai X.Y., Qin Y., Liu H.J., Cui Z.H., Li M., Yang J.H., Zhong W.L., Liu Y.R., Chen S., Sun T., et al. Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-kappaB signaling. Oncotarget. 2017;8:100216\u2013100226. doi: 10.18632/oncotarget.22145.", "ArticleIdList": ["10.18632/oncotarget.22145", "PMC5725014", "29245972"]}, {"Citation": "Sugimoto S., Naganuma M., Kiyohara H., Arai M., Ono K., Mori K., Saigusa K., Nanki K., Takeshita K., Takeshita T., et al. Clinical efficacy and safety of oral Qing-Dai in patients with ulcerative colitis: A single-center open-label prospective study. Digestion. 2016;93:193\u2013201. doi: 10.1159/000444217.", "ArticleIdList": ["10.1159/000444217", "26959688"]}, {"Citation": "Yoshimatsu Y., Naganuma M., Sugimoto S., Tanemoto S., Umeda S., Fukuda T., Nomura E., Yoshida K., Ono K., Mutaguchi M., et al. Development of an Indigo Naturalis Suppository for Topical Induction Therapy in Patients with Ulcerative Colitis. Digestion. 2019 doi: 10.1159/000501152.", "ArticleIdList": ["10.1159/000501152", "31238326"]}, {"Citation": "Langille M.G., Zaneveld J., Caporaso J.G., McDonald D., Knights D., Reyes J.A., Clemente J.C., Burkepile D.E., Vega Thurber R.L., Knight R., et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 2013;31:814\u2013821. doi: 10.1038/nbt.2676.", "ArticleIdList": ["10.1038/nbt.2676", "PMC3819121", "23975157"]}, {"Citation": "Schwab C., Berry D., Rauch I., Rennisch I., Ramesmayer J., Hainzl E., Heider S., Decker T., Kenner L., Muller M., et al. Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery. ISME J. 2014;8:1101\u20131114. doi: 10.1038/ismej.2013.223.", "ArticleIdList": ["10.1038/ismej.2013.223", "PMC3996699", "24401855"]}, {"Citation": "Tao J.H., Duan J.A., Jiang S., Feng N.N., Qiu W.Q., Ling Y. Polysaccharides from Chrysanthemum morifolium Ramat ameliorate colitis rats by modulating the intestinal microbiota community. Oncotarget. 2017;8:80790\u201380803. doi: 10.18632/oncotarget.20477.", "ArticleIdList": ["10.18632/oncotarget.20477", "PMC5655239", "29113344"]}, {"Citation": "Ma X., Hu Y., Li X., Zheng X., Wang Y., Zhang J., Fu C., Geng F. Periplaneta americana ameliorates dextran sulfate sodium-induced ulcerative colitis in rats by Keap1/Nrf-2 activation, intestinal barrier function, and gut microbiota regulatiog. Front. Pharmacol. 2018;9:944. doi: 10.3389/fphar.2018.00944.", "ArticleIdList": ["10.3389/fphar.2018.00944", "PMC6113651", "30186174"]}, {"Citation": "Munyaka P.M., Rabbi M.F., Khafipour E., Ghia J.E. Acute dextran sulfate sodium (DSS)-induced colitis promotes gut microbial dysbiosis in mice. J. Basic Microbiol. 2016;56:986\u2013998. doi: 10.1002/jobm.201500726.", "ArticleIdList": ["10.1002/jobm.201500726", "27112251"]}, {"Citation": "Bosshard P.P., Zbinden R., Altwegg M. Turicibacter sanguinis gen. nov., sp. nov., a novel anaerobic, Gram-positive bacterium. Int. J. Syst. Evol. Microbiol. 2002;52:1263\u20131266. doi: 10.1099/00207713-52-4-1263.", "ArticleIdList": ["10.1099/00207713-52-4-1263", "12148638"]}, {"Citation": "Brook I. Infectious Diseases. Anaerob. Bact. 2017;2:1628\u20131644."}, {"Citation": "Zheng H., Chen M., Li Y., Wang Y., Wei L., Liao Z., Wang M., Ma F., Liao Q., Xie Z. Modulation of Gut Microbiome Composition and Function in Experimental Colitis Treated with Sulfasalazine. Front. Microbiol. 2017;8:1703. doi: 10.3389/fmicb.2017.01703.", "ArticleIdList": ["10.3389/fmicb.2017.01703", "PMC5594074", "28936203"]}, {"Citation": "Oz H.S., Chen T., de Villiers W.J. Green Tea Polyphenols and Sulfasalazine have Parallel Anti-Inflammatory Properties in Colitis Models. Front. Immunol. 2013;4:132. doi: 10.3389/fimmu.2013.00132.", "ArticleIdList": ["10.3389/fimmu.2013.00132", "PMC3672863", "23761791"]}, {"Citation": "Cooper H.S., Murthy S.N., Shah R.S., Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Investig. A J. Tech. Methods Pathol. 1993;69:238\u2013249.", "ArticleIdList": ["8350599"]}, {"Citation": "Tuan N.N., Chang Y.C., Yu C.P., Huang S.L. Multiple approaches to characterize the microbial community in a thermophilic anaerobic digester running on swine manure: A case study. Microbiol. Res. 2014;169:717\u2013724. doi: 10.1016/j.micres.2014.02.003.", "ArticleIdList": ["10.1016/j.micres.2014.02.003", "24629524"]}, {"Citation": "Mago\u010d T., Salzberg S.L. FLASH: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27:2957\u20132963. doi: 10.1093/bioinformatics/btr507.", "ArticleIdList": ["10.1093/bioinformatics/btr507", "PMC3198573", "21903629"]}, {"Citation": "Bolger A.M., Lohse M., Usadel B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u20132120. doi: 10.1093/bioinformatics/btu170.", "ArticleIdList": ["10.1093/bioinformatics/btu170", "PMC4103590", "24695404"]}, {"Citation": "Edgar R.C., Haas B.J., Clemente J.C., Quince C., Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 2011;27:2194\u20132200. doi: 10.1093/bioinformatics/btr381.", "ArticleIdList": ["10.1093/bioinformatics/btr381", "PMC3150044", "21700674"]}, {"Citation": "Edgar R.C. UPARSE: Highly accurate OTU sequences from microbial amplicon reads. Nat. Methods. 2013;10:996\u2013998. doi: 10.1038/nmeth.2604.", "ArticleIdList": ["10.1038/nmeth.2604", "23955772"]}, {"Citation": "Wang Q., Garrity G.M., Tiedje J.M., Cole J.R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 2007;73:5261\u20135267. doi: 10.1128/AEM.00062-07.", "ArticleIdList": ["10.1128/AEM.00062-07", "PMC1950982", "17586664"]}, {"Citation": "Quast C., Pruesse E., Yilmaz P., Gerken J., Schweer T., Yarza P., Peplies J., Glockner F.O. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res. 2013;41:590\u2013596. doi: 10.1093/nar/gks1219.", "ArticleIdList": ["10.1093/nar/gks1219", "PMC3531112", "23193283"]}, {"Citation": "Schloss P.D., Gevers D., Westcott S.L. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS ONE. 2011;6:e27310. doi: 10.1371/journal.pone.0027310.", "ArticleIdList": ["10.1371/journal.pone.0027310", "PMC3237409", "22194782"]}, {"Citation": "Wang Y., Sheng H.F., He Y., Wu J.Y., Jiang Y.X., Tam N.F., Zhou H.W. Comparison of the levels of bacterial diversity in freshwater, intertidal wetland, and marine sediments by using millions of illumina tags. Appl. Environ. Microbiol. 2012;78:8264\u20138271. doi: 10.1128/AEM.01821-12.", "ArticleIdList": ["10.1128/AEM.01821-12", "PMC3497375", "23001654"]}, {"Citation": "Segata N., Izard J., Waldron L., Gevers D., Miropolsky L., Garrett W.S., Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:60. doi: 10.1186/gb-2011-12-6-r60.", "ArticleIdList": ["10.1186/gb-2011-12-6-r60", "PMC3218848", "21702898"]}, {"Citation": "Parks D.H., Tyson G.W., Hugenholtz P., Beiko R.G. STAMP: Statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014;30:3123\u20133124. doi: 10.1093/bioinformatics/btu494.", "ArticleIdList": ["10.1093/bioinformatics/btu494", "PMC4609014", "25061070"]}]}], "History": [{"Year": "2019", "Month": "9", "Day": "29"}, {"Year": "2019", "Month": "10", "Day": "18"}, {"Year": "2019", "Month": "11", "Day": "8"}, {"Year": "2019", "Month": "11", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["31726738", "PMC6891465", "10.3390/molecules24224086", "molecules24224086"]}}]}